TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed Mar 30, 2020 · 10-K · 90 days after period end · 0001558370-20-003346
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|
| Revenue | $4.86M | — |
| Net Income | -$6.53M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end
